See below

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

EU CTR

Registry ID

EUCTR2017-005146-30-SE

Enrollment

Registered

2018-09-14

Start date

2018-11-05

Completion date

Unknown

Last updated

2025-01-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

See below MedDRA version: 20.0 Level: PT Classification code 10036276 Term: Postoperative analgesia System Organ Class: 10042613 - Surgical and medical procedures

Interventions

Trade Name: OxyContin 5 mg depottabletter Pharmaceutical Form: Prolonged-release tablet INN or Proposed INN: Oxycodone hydrochloride CAS Number: 124-90-3 Other descriptive name: OXYCODONE HYDROCHLORID

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: See below Are the trial subjects under 18? no Number of subjects for this age range: F.1.2 Adults (18-64 years) yes F.1.2.1 Number of subjects for this age range 20 F.1.3 Elderly (>=65 years) no F.1.3.1 Number of subjects for this age range

Exclusion criteria

Exclusion criteria: See below

Design outcomes

Primary

Measure	Time frame
Main Objective: See below;Secondary Objective: See below;Primary end point(s): See below;Timepoint(s) of evaluation of this end point: See below	—

Secondary

Measure	Time frame
Secondary end point(s): See below;Timepoint(s) of evaluation of this end point: See below	—

Countries

Sweden

Contacts

Public ContactKlara Thorsson, project manager

Gothia Forum

klara.thorsson@vgregion.se

Outcome results

None listed

Source: EU CTR (via WHO ICTRP) · Data processed: Feb 4, 2026